Product Information

POTASSIUM CL ER 8 MEQ CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.0936 per EA under NDC 43547055210. Its NADAC has been published 272 times since Jun 9, 2021.

FDA first approved this application on Jun 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 8 MEQ CAPSULE

potassium chloride
$0.0936per EA

Strength

600 mg/1

NDC

43547055210

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209026

FDA Approved

6/11/2019

TE Code

AB

On Market Since

3/14/2019

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has been published 272 times since Jun 9, 2021, and over the history we have for it it has declined 66.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0936 per EA
All-time high$0.3060 (Sep 15, 2021)
All-time low$0.0914 (Jul 22, 2026)
52-week high$0.1415
52-week low$0.0914
Median price$0.1460
Average price$0.1579
Largest weekly change-44.0% (Nov 23, 2022)
Weeks tracked272
Tracking sinceJun 9, 2021

Price History

1W

+2.4%

1M

+2.4%

3M

-15.9%

6M

-21.8%

1Y

-33.9%

3Y

-52.3%

5Y

-69.4%

All

-66.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the potassium chloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 8 MEQ CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ CAPSULE, manufactured by Solco Healthcare US LLC, is $0.0936 per EA (NDC 43547055210), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 8 MEQ CAPSULE changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has declined 66.8%. It has been tracked across 272 weekly CMS publications since Jun 9, 2021.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ CAPSULE?

Since Jun 9, 2021, the NADAC for POTASSIUM CL ER 8 MEQ CAPSULE has ranged from a low of $0.0914 (Jul 22, 2026) to a high of $0.3060 (Sep 15, 2021), with a median of $0.1460 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CL ER 8 MEQ CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CL ER 8 MEQ CAPSULE?

POTASSIUM CL ER 8 MEQ CAPSULE (NDC 43547055210) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.